Cara Therapeutics (NQ: CARA )

13.15 USD -0.07 (-0.53%)

Streaming Delayed Price Updated: 1:58 PM EDT, Oct 29, 2020 Add to My Watchlist

Price and Volume

Volume	212,985
Open	13.20
Bid (Size)	13.16 (2)
Ask (Size)	13.20 (3)
Prev. Close	13.22
Today's Range	12.89 - 13.25
52wk Range	8.880 - 26.67
Shares Outstanding	33,874,770
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

SWK Holdings' Subsidiary, Enteris BioPharma, Receives Milestone Payment from Cara Therapeutics

October 27, 2020

First of multiple anticipated milestone payments related to the development of Oral KORSUVA™

Cara Therapeutics Announces Presentation at American Society of Nephrology Kidney Week 2020

October 21, 2020

Performance

YTD	-14.83%	-14.83%
1 Month	+6.05%	+6.05%
3 Month	-22.14%	-22.14%
6 Month	-17.19%	-17.19%
1 Year	-35.41%	-35.41%

More News

Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis patients with pruritus

October 20, 2020

Titan Pharmaceuticals Provides a Strategic & Corporate Update

October 15, 2020

Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer

October 01, 2020

Cara Therapeutics Reports Second Quarter 2020 Financial Results

August 10, 2020

Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus

October 20, 2020

Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference

August 06, 2020

Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020

August 03, 2020

Why Cara Therapeutics Stock Is Trading Higher Today

October 20, 2020

Return On Capital Employed Overview: Cara Therapeutics

October 20, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.